1. Home
  2. MIST vs ODYS Comparison

MIST vs ODYS Comparison

Compare MIST & ODYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • ODYS
  • Stock Information
  • Founded
  • MIST 2003
  • ODYS N/A
  • Country
  • MIST Canada
  • ODYS Israel
  • Employees
  • MIST N/A
  • ODYS N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • ODYS
  • Sector
  • MIST Health Care
  • ODYS
  • Exchange
  • MIST Nasdaq
  • ODYS NYSE
  • Market Cap
  • MIST 89.8M
  • ODYS 86.1M
  • IPO Year
  • MIST N/A
  • ODYS N/A
  • Fundamental
  • Price
  • MIST $1.71
  • ODYS $4.91
  • Analyst Decision
  • MIST Strong Buy
  • ODYS Strong Buy
  • Analyst Count
  • MIST 2
  • ODYS 1
  • Target Price
  • MIST $7.50
  • ODYS $10.00
  • AVG Volume (30 Days)
  • MIST 658.4K
  • ODYS 8.2K
  • Earning Date
  • MIST 08-07-2025
  • ODYS 08-11-2025
  • Dividend Yield
  • MIST N/A
  • ODYS N/A
  • EPS Growth
  • MIST N/A
  • ODYS N/A
  • EPS
  • MIST N/A
  • ODYS N/A
  • Revenue
  • MIST N/A
  • ODYS $5,842,000.00
  • Revenue This Year
  • MIST N/A
  • ODYS N/A
  • Revenue Next Year
  • MIST N/A
  • ODYS N/A
  • P/E Ratio
  • MIST N/A
  • ODYS N/A
  • Revenue Growth
  • MIST N/A
  • ODYS 100.27
  • 52 Week Low
  • MIST $0.63
  • ODYS $4.83
  • 52 Week High
  • MIST $2.75
  • ODYS $10.80
  • Technical
  • Relative Strength Index (RSI)
  • MIST 60.15
  • ODYS N/A
  • Support Level
  • MIST $1.67
  • ODYS N/A
  • Resistance Level
  • MIST $1.80
  • ODYS N/A
  • Average True Range (ATR)
  • MIST 0.08
  • ODYS 0.00
  • MACD
  • MIST -0.01
  • ODYS 0.00
  • Stochastic Oscillator
  • MIST 43.24
  • ODYS 0.00

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About ODYS ODYSIGHT AI INC

Odysight ai Inc is engaged in the development, production, and marketing of Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) technologies, providing visual sensing and AI-based video analytics solutions for critical systems in the aviation, maritime, industrial non-destructing-testing industries, transportation, and energy industries.

Share on Social Networks: